Quantcast

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.

Research paper by J M JM Maris, C C Guo, P S PS White, M D MD Hogarty, P M PM Thompson, D O DO Stram, R R Gerbing, K K KK Matthay, R C RC Seeger, G M GM Brodeur

Indexed on: 24 Jul '01Published on: 24 Jul '01Published in: Medical and pediatric oncology



Abstract

Neuroblastoma tumorigenesis may involve the differential inactivation of multiple tumor suppressor genes. Recent data have suggested that a neuroblastoma suppressor gene may be located on the long arm of chromosome 11 (11q).We therefore analyzed 295 primary neuroblastomas from a representative group of patients for loss of heterozygosity (LOH) at 25 polymorphic markers spanning 11q.LOH was observed in 129 primary neuroblastomas (44%), and a common region of LOH mapped to 11q14-23. No correlation was found between 11q LOH and adverse prognostic variables, but a strong inverse relationship between 11q LOH and MYCN amplification (P < 0.001) was observed. There was no difference in overall survival when patients were stratified by 11q LOH status. However, 11q LOH was associated with a decreased overall survival probability when patients whose tumors had a single copy of MYCN were analyzed separately (P = 0.008).These data support the hypothesis that a tumor suppressor gene mapping within 11q14-23 is frequently inactivated during the malignant evolution of neuroblastoma.